Results 41 to 50 of about 600,253 (216)

“Clozapine & Valbenazine for Treatment of Tardive Cervical Dystonia: A Case Report”

open access: yesTranslation, 2023
Cervical dystonia is a subtype of tardive dyskinesia characterized by smooth, sustained muscle contractions affecting the head, neck, and shoulders. This condition can be caused by antipsychotic medication exposure.
Chandani Lewis, Christine Brennan
doaj   +1 more source

Cervical Dystonia Mimics: A Case Series and Review of the Literature

open access: yesTremor and Other Hyperkinetic Movements, 2019
Background: Cervical dystonia is mostly idiopathic in nature. However, a small subset of cases are mimics, leading to diagnostic pitfalls. There is paucity of literature on pseudodystonias affecting the cervical region.
Srinivas Raju, Amogh Ravi, LK Prashanth
doaj   +1 more source

Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia

open access: yesScientific Reports, 2021
In cervical dystonia, functional MRI (fMRI) evidence indicates changes in several resting state networks, which revert in part following the botulinum neurotoxin A (BoNT) therapy.
P. Hok   +8 more
semanticscholar   +1 more source

Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure

open access: yesNeuroImage: Clinical, 2018
Objective: Isolated adult-onset focal dystonia is considered a network disorder with disturbances to the motor basal ganglia and cerebellar circuits playing a pathophysiological role, but why specific body regions become affected remains unknown.
Brian D. Berman   +4 more
doaj   +1 more source

Explicit Agency in Patients with Cervical Dystonia: Altered Recognition of Temporal Discrepancies between Motor Actions and Their Feedback. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Abnormalities in the cognitive processing of movement have been demonstrated in patients with dystonia. The sense of agency, which is the experience of initiating and controlling one's own actions, has never before been studied in these ...
Cécile Delorme   +6 more
doaj   +1 more source

Cervical Dystonia Is Associated With Aberrant Inhibitory Signaling Within the Thalamus

open access: yesFrontiers in Neurology, 2021
Objective: The objective of this study is to investigate whether alterations in the neurotransmission of gamma-aminobutyric acid (GABA) in the thalamus are present in patients with cervical dystonia compared to healthy controls.
C. Groth   +5 more
semanticscholar   +1 more source

Non‐motor phenotypic subgroups in adult‐onset idiopathic, isolated, focal cervical dystonia

open access: yesBrain and Behavior, 2021
Background: Non‐motor symptoms are well established phenotypic components of adult‐onset idiopathic, isolated, focal cervical dystonia (AOIFCD). However, improved understanding of their clinical heterogeneity is needed to better target therapeutic ...
Megan E. Wadon   +21 more
semanticscholar   +1 more source

Botulinum toxin type A versus anticholinergics for cervical dystonia.

open access: yesCochrane Database of Systematic Reviews, 2021
BACKGROUND This is an update of a Cochrane Review first published in 2005. Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder, characterised by involuntary, usually painful, head posturing.
Filipe B Rodrigues   +7 more
semanticscholar   +1 more source

Impact of Depression on Cognitive Function and Disease Severity in Idiopathic Cervical Dystonia Patients: One-Center Data in Cross-Sectional Study

open access: yesMedicina, 2022
Background: Cervical dystonia is a highly disabling hyperkinetic movement disorder with a lot of nonmotor symptoms. One symptom with a high prevalence is depression, which may negatively affect dystonia patients.
Vlada Meļņikova   +3 more
doaj   +1 more source

Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia

open access: yesNeurology
Background and Objectives ASPEN-1 was a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of DaxibotulinumtoxinA for Injection (DAXI), a novel botulinum toxin type A ...
Cynthia L. Comella   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy